Proprietary bioelectronic devices developed by Endonovo Therapeutics target patient pain and inflammation while aiding wound recovery SofPulse® safely decreases pain by reducing edema (swelling), which decreases the need for prescription pain medications Endonovo’s wearable device can be used to address an array of medical conditions and is FDA-cleared for treating post-operative pain and edema in […]

Trxade hosts a S2P (supplier to pharmacy) pharmaceuticals trading platform Over 10,500 registered pharmacies are listed on Trxade’s platform The company achieved record first quarter 2019 financial results driven by an increase in revenues The proprietors of America’s independent pharmacies may well be cheering as the S2P (supplier to pharmacy) trading platform pioneered by Trxade […]

Lexaria developed and out-licenses DehydraTECH to create new (and improve existing) drug-delivery products The company is credited with leading the way forward in discovering new ways to effectively deliver CBD into the human body Lexaria is helping firms meet supply and demand requirements by creating products that offer lower dosing with higher absorption Lexaria Bioscience […]

SGSI is focused on creating and maintaining excellent customer relationships, along with providing proven value, quality, safety and reliability The company maintains high standards as it seeks out additional acquisitions SGSI is strategically positioned to meet rising demand for 5G, which offers the potential of creating three million jobs, safer cities and stronger economies Described […]

Legislative changes pertaining to hemp company registration in California are expected to enable widespread cultivation in the state Green Hygienics Holdings has already acquired a cultivation license in San Diego County to make full use of the growing California market The U.S. hemp industry is forecast to grow rapidly in the years to come; sales […]

Appointment of Dr. Steven Levin of Johns Hopkins University to Endonovo’s scientific advisory board is expected to help facilitate the introduction of Endonovo’s non-invasive bio-electrical medical devices to hospitals and clinics The global wearable medical devices market is expected to grow to nearly $67 billion by 2026 at a CAGR of 26.1 percent Endonovo holds […]

Nabis Holdings has closed on its previously announced initial purchase of a 49 percent interest in Cannova Medical Ltd., with an option to purchase the remaining 51 percent The company selected Cannova Medical for its unique approach to consumable cannabis technology and untapped industry potential Nabis sees Cannova as a potential disruptor in the edible […]

TRXD sales grew to $1.5 million in Q1 2019; operating income also rose when compared to the same period of the prior year The company is adding new independent pharmacies and increasing pharmacy sales Mail-order pharmacy services and a newly launched mobile app offer lower prescription drug costs for U.S. consumers Trxade Group Inc. (OTCQB: […]

Sproutly is a licensed producer with exclusive rights to Infusion Biosciences’ groundbreaking Aqueous Phytorecovery Process (“APP”) technology for naturally water-soluble cannabinoids Deloitte estimates that Canada’s cannabis edibles and topicals market could be worth $2.7 billion annually The company has entered into an exclusive joint venture with Moosehead Breweries Limited to develop and produce nonalcoholic, cannabis-infused […]

The new version of the DehydraTECH delivery platform is suitable for use in pills, capsules and tablets for the pharmaceutical, medical and supplement markets DehydraTECH has demonstrated that it can deliver eight times more CBD into the blood than standard industry formulations Animal testing shows that combining DehydraTECH with a nanoemulsion formulation greatly assists delivery […]